| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |